Kura Oncology, Inc.KURANASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-290.02M
↓ 151% vs avg
Percentile
P0
Near historical low
Streak
9 yr
Consecutive declineContracting
Average
$-115.77M
Historical baseline
PeriodValueYoY Change
TTM$-290.02M-71.1%
2024$-169.50M-12.8%
2023$-150.23M-11.4%
2022$-134.85M-4.1%
2021$-129.49M-45.7%
2020$-88.85M-31.7%
2019$-67.47M-7.3%
2018$-62.87M-74.4%
2017$-36.05M-27.2%
2016$-28.34M-